P. H. Wiernik

743 total citations
19 papers, 526 citations indexed

About

P. H. Wiernik is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, P. H. Wiernik has authored 19 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Hematology and 3 papers in Genetics. Recurrent topics in P. H. Wiernik's work include Neutropenia and Cancer Infections (5 papers), Cancer Treatment and Pharmacology (4 papers) and Acute Myeloid Leukemia Research (3 papers). P. H. Wiernik is often cited by papers focused on Neutropenia and Cancer Infections (5 papers), Cancer Treatment and Pharmacology (4 papers) and Acute Myeloid Leukemia Research (3 papers). P. H. Wiernik collaborates with scholars based in United States, Malaysia and Australia. P. H. Wiernik's co-authors include Joseph Aisner, S. C. Schimpff, James H. Duncan, Stephen C. Schimpff, Viola Mae Young, William H. Greene, CA Schiffer, S Misawa, Nobuo Oguma and Joseph R. Testa and has published in prestigious journals such as The Lancet, The Journal of Infectious Diseases and Transfusion.

In The Last Decade

P. H. Wiernik

19 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. H. Wiernik United States	11	174	162	90	66	60	19	526
R. G. Graw United States	18	314 1.8×	372 2.3×	42 0.5×	55 0.8×	35 0.6×	24	796
Sheldon C. Naiman Canada	13	95 0.5×	391 2.4×	83 0.9×	101 1.5×	97 1.6×	28	893
Pierre Wacker Switzerland	15	119 0.7×	365 2.3×	118 1.3×	81 1.2×	137 2.3×	38	794
C. H. Tzeng Taiwan	13	133 0.8×	180 1.1×	55 0.6×	43 0.7×	53 0.9×	34	491
Andreu Llorente Spain	11	85 0.5×	163 1.0×	170 1.9×	13 0.2×	121 2.0×	20	491
Michele W. Sugrue United States	14	135 0.8×	320 2.0×	26 0.3×	55 0.8×	46 0.8×	27	668
Hillard M. Lazarus United States	13	116 0.7×	166 1.0×	40 0.4×	53 0.8×	72 1.2×	15	545
Kahan Bd United States	16	99 0.6×	50 0.3×	62 0.7×	15 0.2×	130 2.2×	85	670
Aaron Cumpston United States	17	199 1.1×	295 1.8×	54 0.6×	13 0.2×	59 1.0×	55	722
Dennis A. Casciato United States	10	70 0.4×	117 0.7×	64 0.7×	4 0.1×	65 1.1×	20	489

Countries citing papers authored by P. H. Wiernik

Since Specialization

Citations

This map shows the geographic impact of P. H. Wiernik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. H. Wiernik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. H. Wiernik more than expected).

Fields of papers citing papers by P. H. Wiernik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. H. Wiernik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. H. Wiernik. The network helps show where P. H. Wiernik may publish in the future.

Co-authorship network of co-authors of P. H. Wiernik

This figure shows the co-authorship network connecting the top 25 collaborators of P. H. Wiernik. A scholar is included among the top collaborators of P. H. Wiernik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. H. Wiernik. P. H. Wiernik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Alexandrescu, Doru T, Niyati Bhagwati, & P. H. Wiernik. (2005). Chemotherapy-induced scleroderma: a pleiomorphic syndrome. Clinical and Experimental Dermatology. 30(2). 141–145. 25 indexed citations

Dutcher, Janice P. & P. H. Wiernik. (1993). The role of recombinant interleukin-2 in therapy for hematologic malignancies.. PubMed. 20(6 Suppl 9). 33–40. 6 indexed citations

Rowe, Jacob M., J. W. Andersen, Peter A. Cassileth, et al.. (1992). Post-remission therapy in adults with acute myelogenous leukemia: the Eastern Cooperative Oncology Group (ECOG) experience.. PubMed. 6 Suppl 4. 75–7. 6 indexed citations

Marmont, A, E. A. McCulloch, J. K. H. Rees, Peter Reizenstein, & P. H. Wiernik. (1990). New Approaches to the Treatment of Leukemia. 4 indexed citations

Bishop, James F., CA Schiffer, Joseph Aisner, JP Matthews, & P. H. Wiernik. (1987). Surgery in acute leukemia: A review of 167 operations in thrombocytopenic patients. American Journal of Hematology. 26(2). 147–155. 41 indexed citations

Testa, Joseph R., et al.. (1985). Chromosomal alterations in acute leukemia patients studied with improved culture methods.. PubMed. 45(1). 430–4. 75 indexed citations

Schiffer, CA, Christian W. Keller, Janice P. Dutcher, et al.. (1983). Potential HLA‐matched platelet donor availability for alloimmunized patients. Transfusion. 23(4). 286–289. 27 indexed citations

Schiffer, CA, et al.. (1982). A clinical program of platelet cryopreservation.. PubMed. 88. 165–80. 19 indexed citations

Ostrow, S., Merrill J. Egorin, Joseph Aisner, N R Bachur, & P. H. Wiernik. (1980). High-dose cis-diamminedichloro-platinum therapy in patients with advanced breast cancer: pharmacokinetics, toxicity, and therapeutic efficacy.. PubMed. 3(1). 23–7. 42 indexed citations

10.

Echo, David A. Van, Joseph Aisner, & P. H. Wiernik. (1979). Combination chemotherapy of advanced breast cancer with adriamycin and VP 16-213. 20. 2 indexed citations

11.

Daly, Peter A., Charles A. Schiffer, Joseph Aisner, & P. H. Wiernik. (1979). A Comparison of Platelets Prepared by the Haemonetics Model 30 and Multiunit Bag Plateletpheresis. Transfusion. 19(6). 778–781. 9 indexed citations

12.

Schiffer, Charles A., Joseph Aisner, & P. H. Wiernik. (1978). Platelet transfusion therapy for patients with leukemia.. PubMed. 28. 267–79. 17 indexed citations

13.

Schiffer, Charles A., Joseph Aisner, & P. H. Wiernik. (1977). Current status of granulocyte transfusion therapy.. PubMed. 13. 281–92. 8 indexed citations

14.

Schimpff, S. C., et al.. (1975). LEUKÆMIA AND LYMPHOMA PATIENTS INTERLINKED BY PRIOR SOCIAL CONTACT. The Lancet. 305(7899). 124–129. 34 indexed citations

15.

Schimpff, Stephen C., William H. Greene, Viola Mae Young, & P. H. Wiernik. (1974). Significance of Pseudomonas aeruginosa in the Patient with Leukemia or Lymphoma. The Journal of Infectious Diseases. 130(Supplement). S24–S31. 86 indexed citations

16.

Silen, William, et al.. (1973). RECTAL ABSCESSES IN CANCER PATIENTS. The Lancet. 301(7802). 553–554. 3 indexed citations

17.

Wiernik, P. H.. (1972). BLUE SCLERÆ. The Lancet. 300(7788). 1199–1199. 3 indexed citations

18.

Schimpff, S. C., et al.. (1972). RECTAL ABSCESSES IN CANCER PATIENTS. The Lancet. 300(7782). 844–847. 73 indexed citations

19.

Wiernik, P. H. & James H. Duncan. (1971). CYCLOPHOSPHAMIDE IN HUMAN MILK. The Lancet. 297(7705). 912–912. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact